Dietary fiber intake, genetic predisposition of gut microbiota, and the risk of metabolic dysfunction-associated steatotic liver disease
- PMID: 40356189
- DOI: 10.1016/j.foodres.2025.116497
Dietary fiber intake, genetic predisposition of gut microbiota, and the risk of metabolic dysfunction-associated steatotic liver disease
Abstract
This study aimed to explore the association between dietary fiber intake and the risk of metabolic dysfunction-associated steatotic liver disease (MASLD), as well as liver fat content, while considering genetic predispositions of MASLD, gut microbial abundance, and butyrate levels. This study analyzed data from 190,276 participants in the UK Biobank. Dietary fiber intake was assessed using 24-h dietary recall. MASLD cases were diagnosed through hospital admission records and death registries, and liver fat content was measured via magnetic resonance imaging. The genetic predispositions of MASLD, gut microbial abundance, and butyrate levels were evaluated using single nucleotide polymorphisms. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95 % confidence intervals (CIs). Over a median follow-up of 10.49 years, 1423 MASLD cases were recorded. Elevated dietary fiber intake was associated with a reduced risk of MASLD (HR: 0.72; 95 % CI: 0.58, 0.90) and a lower level of liver fat content (β: -0.97; 95 % CI: -1.21, -0.73) (all P for trend <0.05). Restricted cubic spline analyses further confirmed the linear inverse associations between fiber intake and the risk of MASLD. Notably, the negative associations between dietary fiber intake and both MASLD and liver fat content were consistent across different genetic predispositions of gut microbial abundance and butyrate levels. Moreover, the inverse association between dietary fiber intake and liver fat was strengthened by high genetic susceptibility of MASLD and elevated body mass index (both P for interaction <0.05). Overall, increased dietary fiber consumption was associated with a lower MASLD risk and decreased liver fat content regardless of genetic predispositions of gut microbial abundance and butyrate levels.
Keywords: Cohort study; Fiber intake; Genetic predisposition; Liver fat; MASLD; UK biobank.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The moderating effect of dietary fiber intake on the association between sleep pattern and liver fibrosis in metabolic dysfunction-associated steatotic liver disease: a study from NHANES.BMC Gastroenterol. 2024 Dec 18;24(1):457. doi: 10.1186/s12876-024-03538-8. BMC Gastroenterol. 2024. PMID: 39695427 Free PMC article.
-
Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes.J Transl Med. 2024 Jul 12;22(1):650. doi: 10.1186/s12967-024-05478-z. J Transl Med. 2024. PMID: 38997780 Free PMC article.
-
Combination of dietary fiber and exercise training improves fat loss in mice but does not ameliorate MASLD more than exercise alone.Am J Physiol Gastrointest Liver Physiol. 2025 Apr 1;328(4):G399-G410. doi: 10.1152/ajpgi.00317.2024. Epub 2025 Mar 4. Am J Physiol Gastrointest Liver Physiol. 2025. PMID: 40033967
-
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Nutrients. 2024 Dec 31;17(1):143. doi: 10.3390/nu17010143. Nutrients. 2024. PMID: 39796579 Free PMC article. Review.
-
Dietary inflammatory potential and metabolic (dysfunction)-associated steatotic liver disease and its complications: A comprehensive review.Clin Nutr ESPEN. 2025 Feb;65:162-171. doi: 10.1016/j.clnesp.2024.11.032. Epub 2024 Nov 26. Clin Nutr ESPEN. 2025. PMID: 39608495 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical